International Financing Sources
Horizon 2020
Horizon 2020 is the EU research programme for the period 2014 - 2020. The programme funds research and innovation projects that will help solve societal challenges, create more jobs and contribute to economic growth in Europe. These goals are incorporated in European strategies such as European Research Area, Europe 2020 and Innovation Union.
H2020 is one of the most important measures to help achieve the goals. H2020 has three focus areas; Excellent Science, Industrial Leadership and Societal Challenges, all of which are relevant for medical and health research environments. Excellent Science finances independent research. Industrial Leadership is mainly aimed at companies, but often asks for/requires collaboration with academic research environments. Societal Challenges are divided into themes/challenges such as health, food/agriculture, climate, transport and social security.
The calls have defined issues that EU wants solved. A project must have a minimum of 3 research institutions and/or companies from a minimum of 3 different EU member states or associated countries.
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/programmes/h2020
Horizon Europe is EU’s research programme for the period 2020 – 2026. Horizon Europe will build on Horizon 2020.
Innovative Medicines Intitiative 2 (IMI2)
IMI is a public-private partnership between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The goal is to promote the development of better and safer drugs. IMI facilitates collaboration between the key players involved in health research; hospitals, universities, pharmaceutical and other industries, small and medium-sized businesses, patient organisations and regulatory authorities.
Active and Assisted Living Programme (AAL)
AAL will create better quality of life for the elderly and strengthen industrial opportunities in technology and innovation related to aging. AAL finances projects that develop market-ready products and services for the elderly. Each project consists of small and medium-sized companies, research bodies and end-user organisations. The projects are aimed at topics such as chronic conditions, social inclusion, access to digital services, mobility and coping with daily activities.
Joint Programming Initiatives
Joint Program Initiatives (JPI) are European joint programmes organized in various thematic challenges. Norwegian researchers can apply for project funding through calls where Norway participates. 10 JPIs have been established, among others on antimicrobial resistance, neurodegenerative diseases and food and health. Norway participates in all of them.
https://www.era-learn.eu/partnerships-in-a-nutshell/type-of-networks/joint-programming-initiatives
ERA-NETs
ERA-NET is a collaboration between national research programmes for the coordination and strengthening of publicly funded research in Europe. Norway participates in ERA-NET within areas such as cancer, personalized medicine, cardiovascular diseases, diseases affecting the nervous system and the brain, and nanomedicine.
https://www.era-learn.eu/network-information
National Institutes of Health - USA
The National Institutes of Health consists of 27 different institutes and centres. Each has its own specific research agenda, which often focuses on specific diseases or diagnostic groups. NIH supports research within e.g. causal relationships, diagnosis, prevention and cure of human diseases, processes of human growth and development, biological effects of environmental toxins, and the understanding of mental, addictive and physical disorders.